Clinical Trials in Ryazan, Russia
17 recruiting
Showing 1–19 of 19 trials
Recruiting
ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia
AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AstraZeneca110 enrolled9 locationsNCT07399665
Recruiting
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
Uncontrolled Asthma
AstraZeneca9,000 enrolled47 locationsNCT06521229
Recruiting
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
Breast Cancer
Novartis Pharmaceuticals2,766 enrolled37 locationsNCT06930859
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Chronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+1 more
Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686
Recruiting
Phase 3
A Study of Daratumumab
Multiple Myeloma
Janssen Research & Development, LLC500 enrolled91 locationsNCT05438043
Recruiting
Registry of Arterial Hypertension
Arterial Hypertension
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation10,400 enrolled17 locationsNCT04160533
Recruiting
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Severe Asthma
AstraZeneca5,000 enrolled37 locationsNCT06472310
Recruiting
Phase 3
Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years
Acute Respiratory Viral Infection
Materia Medica Holding374 enrolled35 locationsNCT06715891
Recruiting
Phase 3
Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children
Cough
Materia Medica Holding264 enrolled30 locationsNCT07171099
Recruiting
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
AstraZeneca2,000 enrolled41 locationsNCT05887011
Recruiting
Phase 3
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Endometriosis
Alcea290 enrolled8 locationsNCT07164183
Recruiting
Phase 2
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
Biocad124 enrolled47 locationsNCT07108309
Recruiting
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals2,382 enrolled20 locationsNCT06858332
Recruiting
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia
Arterial Hypertension, Chronic Kidney Disease
AstraZeneca10,000 enrolled30 locationsNCT06372431
Recruiting
Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
Obstructive JaundiceGallstone Disease
POLYSAN Scientific & Technological Pharmaceutical Company286 enrolled9 locationsNCT05928286
Recruiting
Myocardial Infarction in the Elderly
Myocardial Infarction (MI)
Ryazan State Medical University1,000 enrolled1 locationNCT06860646
Recruiting
Phase 2Phase 3
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
Candidal Vulvovaginitis (ICD-10 Code: B37.3)Vulvovaginal Candidiasis (VVC)
AVVA Pharmaceuticals Ltd.264 enrolled7 locationsNCT06835361
Recruiting
Not Applicable
Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy
Resistant Arterial Hypertension
Ryazan State Medical University190 enrolled1 locationNCT05899920
Recruiting
Not Applicable
Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
Ryazan State Medical University120 enrolled1 locationNCT05933720